Table 1. Baseline characteristics of KTRs who underwent indication biopsy.
| Variables | Findings (n = 24) |
|---|---|
| Male sex | 16 (66.7) |
| Mean age, yr | 46.1 ± 12.4 |
| Underlying kidney disease | |
| Chronic glomerulonephritis | 14 (58.3) |
| Diabetes | 3 (12.5) |
| Hypertensive nephrosclerosis | 1 (4.2) |
| Cystic disease | 4 (16.7) |
| Others | 2 (8.3) |
| Living donor transplantation | 16 (66.7) |
| Cross-match positive KT | 1 (4.2) |
| ABO incompatible KT | 2 (8.3) |
| Pre-transplant PRA positive | 3 (12.5) |
| The median time from KT to biopsy, mon | 14 (0–94) |
| HLA mismatch number | |
| Total | 3 (0–6) |
| DR | 1 (0–2) |
| Induction treatment | |
| Basiliximab | 24 (100.0) |
| CNI | |
| Tacrolimus | 21 (87.5) |
| Cyclosporine | 3 (12.5) |
Values are shown as mean ± standard deviation, median (range), or frequency (percentage). The percentage PRA and antibody specificity were determined by Luminex assays and PRA > 10% was considered as positive.
KTRs = kidney transplant recipients, KT = kidney transplantation, PRA = panel reactive antibody, HLA = human leukocyte antigen, DR = antigen D related, CNI = calcineurin inhibitor.